A Texas state agency is actively discriminating against white and Asian Texans, refusing them monoclonal antibody treatments because of their ethnicity.
The potentially life-saving monoclonal antibody treatment for those affected with COVID-19 has demonstrated effectiveness if received early enough, yet it is being denied to some patients on the basis of race.
News broke over the weekend that the criteria for receiving the monoclonal antibody treatment excludes those of white or Asian descent who are younger than 65 and reasonably healthy, as determined by their body mass index and health history.
When Smith asked if he could receive the treatment if he was black or Hispanic, the HHS worker replied, "That's right."
Smith added, "So, I'm being denied medical service because of my race?".
Called the State Infusion Hotline and asked if monoclonal antibody treatments were being denied to those of Caucasian and Asian descent if they had no underlying health issues.
Gubernatorial challenger Don Huffines brought attention to the issue, calling it "Outrageous that Greg Abbott's state agencies are actively discriminating against White and Asian Texans-denying them monoclonal antibodies, which is potentially lifesaving treatment."
It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.
Tuesday, November 23, 2021
Potentially Life-Saving Treatment for COVID-19 Denied on Basis of Race
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment